Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goldleaf Pharm Inc., now operating as FIGR Norfolk Inc., is a Canadian licensed producer of medical and recreational cannabis based in Simcoe, Ontario. Originally established as a late-stage applicant for a cultivation license, the company was acquired in 2018 by FIGR Cannabis, a subsidiary of the global agricultural firm Pyxus International (formerly Alliance One International). The company operates a high-tech indoor cultivation facility and focuses on the production of premium cannabis products using advanced agricultural techniques and scientific rigor. Following a restructuring in 2021, the company's assets were acquired by FJSV Enterprises, which continues to operate the facility under the FIGR brand within the Canadian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goldleaf Pharm.